Statins for the prevention of perioperative cardiovascular complications in vascular surgery Olaf Schouten, MD, Jeroen J. Bax, MD, Martin Dunkelgrun, MD, Harm H. Feringa, MD, Hero van Urk, MD, Don Poldermans, MD Journal of Vascular Surgery Volume 44, Issue 2, Pages 419-424 (August 2006) DOI: 10.1016/j.jvs.2006.04.039 Copyright © 2006 The Society for Vascular Surgery Terms and Conditions
Fig 1 Cholesterol-lowering and pleiotropic effects of statins. (Partially derived from Schonbeck U, Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 2004;109:II18-26). Journal of Vascular Surgery 2006 44, 419-424DOI: (10.1016/j.jvs.2006.04.039) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions
Fig 2 Safety of perioperative use. Percentage of statin users and nonusers with normal postoperative creatine kinase (CK) levels, moderately elevated CK levels, and severely elevated CK levels. ULN, Upper limit of normal. Journal of Vascular Surgery 2006 44, 419-424DOI: (10.1016/j.jvs.2006.04.039) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions